Compare TEVA & DHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | DHI |
|---|---|---|
| Founded | 1901 | 1978 |
| Country | Israel | United States |
| Employees | 32842 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.5B | 39.0B |
| IPO Year | N/A | 1995 |
| Metric | TEVA | DHI |
|---|---|---|
| Price | $35.37 | $156.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 14 |
| Target Price | $38.63 | ★ $166.08 |
| AVG Volume (30 Days) | ★ 5.3M | 2.2M |
| Earning Date | 04-29-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 1.19% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.27 |
| Revenue | N/A | ★ $34,250,400,000.00 |
| Revenue This Year | N/A | $0.05 |
| Revenue Next Year | $2.97 | $5.85 |
| P/E Ratio | ★ $28.19 | $37.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.99 | $129.11 |
| 52 Week High | $37.35 | $183.62 |
| Indicator | TEVA | DHI |
|---|---|---|
| Relative Strength Index (RSI) | 59.63 | 52.04 |
| Support Level | $30.59 | $145.76 |
| Resistance Level | $35.33 | $162.93 |
| Average True Range (ATR) | 1.13 | 4.99 |
| MACD | 0.20 | -0.39 |
| Stochastic Oscillator | 97.00 | 25.57 |
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.